- Home
- OTLK vs CVM Comparison
OTLK vs CVM Comparison
Compare OTLK & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OTLK
- CVM
- Stock Information
- Founded
- OTLK 2010
- CVM 1983
- Country
- OTLK United States
- CVM United States
- Employees
- OTLK N/A
- CVM N/A
- Industry
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OTLK Health Care
- CVM Health Care
- Exchange
- OTLK Nasdaq
- CVM Nasdaq
- Market Cap
- OTLK 33.6M
- CVM 40.1M
- IPO Year
- OTLK 2016
- CVM 1987
- Fundamental
- Price
- OTLK $2.01
- CVM $0.60
- Analyst Decision
- OTLK Strong Buy
- CVM
- Analyst Count
- OTLK 6
- CVM 0
- Target Price
- OTLK $28.68
- CVM N/A
- AVG Volume (30 Days)
- OTLK 1.8M
- CVM 1.1M
- Earning Date
- OTLK 12-27-2024
- CVM 02-12-2025
- Dividend Yield
- OTLK N/A
- CVM N/A
- EPS Growth
- OTLK N/A
- CVM N/A
- EPS
- OTLK N/A
- CVM N/A
- Revenue
- OTLK N/A
- CVM N/A
- Revenue This Year
- OTLK N/A
- CVM N/A
- Revenue Next Year
- OTLK N/A
- CVM $3,412.81
- P/E Ratio
- OTLK N/A
- CVM N/A
- Revenue Growth
- OTLK N/A
- CVM N/A
- 52 Week Low
- OTLK $0.87
- CVM $0.49
- 52 Week High
- OTLK $12.85
- CVM $3.23
- Technical
- Relative Strength Index (RSI)
- OTLK 40.39
- CVM 43.71
- Support Level
- OTLK $1.26
- CVM $0.60
- Resistance Level
- OTLK $1.59
- CVM $0.73
- Average True Range (ATR)
- OTLK 0.20
- CVM 0.13
- MACD
- OTLK 0.18
- CVM 0.01
- Stochastic Oscillator
- OTLK 81.52
- CVM 16.97
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company's core capabilities that include are drug discovery, research, development and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.